Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher L Bowlus

Showing results (101-110 of 189) with videos related to

Pageof 19
Sort By:
Hepatology (Baltimore, Md.)|December 20, 2023
Seladelpar treatment reduces IL-31 and pruritus in patients with primary biliary cholangitisAndreas E Kremer, Marlyn J Mayo, Gideon M Hirschfield, et al.
Journal of Gastroenterology and Hepatology|June 24, 2025
Pre-Diagnosis Alkaline Phosphatase and Antimitochondrial Antibody Positivity Vary by Race/Ethnicity Among Patients With Primary Biliary CholangitisAllyce Caines, Mei Lu, Trueman Wu, et al.
Journal of Gastroenterology and Hepatology|April 20, 2026
Author Response to "Comment on Prediagnosis Alkaline Phosphatase and Antimitochondrial Antibody Positivity Vary by Race/Ethnicity Among Patients With Primary Biliary Cholangitis"Allyce Caines, Mei Lu, Trueman Wu, et al.
Gastroenterology|August 13, 2021
Defining Primary Sclerosing Cholangitis: Results From an International Primary Sclerosing Cholangitis Study Group Consensus ProcessCyriel Y Ponsioen, David N Assis, Kirsten M Boberg, et al.
Journal of Gastroenterology|November 11, 2006
Changes in plasma ghrelin levels, gastric ghrelin production, and body weight after Helicobacter pylori cureHiroyuki Osawa, Hiroto Kita, Hirohide Ohnishi, et al.
Journal of Autoimmunity|April 28, 2019
Therapeutic trials of biologics in primary biliary cholangitis: An open label study of abatacept and review of the literatureChristopher L Bowlus, Guo-Xiang Yang, Chung H Liu, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 26, 2018
RARβ acts as both an upstream regulator and downstream effector of miR-22, which epigenetically regulates NUR77 to induce apoptosis of colon cancer cellsYing Hu, Samuel W French, Thinh Chau, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 4, 2026
Impact of Disease-Specific Treatment and Non-Selective Beta Blockers on Risk of PVT in Cirrhotic Patients With HCV or PBCHumberto C Gonzalez, Stuart C Gordon, Sheri Trudeau, et al.
Frontiers in Immunology|September 5, 2022
Decreased CD57 expression of natural killer cells enhanced cytotoxicity in patients with primary sclerosing cholangitisBin Liu, Guo-Xiang Yang, Ying Sun, et al.
Hepatology (Baltimore, Md.)|October 19, 2011
Biochemical and immunologic effects of rituximab in patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acidMasanobu Tsuda, Yuki Moritoki, Zhe-Xiong Lian, et al.
Pageof 19

Showing results (101-110 of 189) with videos related to

Sort By:
Pageof 19
Hepatology (Baltimore, Md.)|December 20, 2023
Seladelpar treatment reduces IL-31 and pruritus in patients with primary biliary cholangitisAndreas E Kremer, Marlyn J Mayo, Gideon M Hirschfield, et al.
Journal of Gastroenterology and Hepatology|June 24, 2025
Pre-Diagnosis Alkaline Phosphatase and Antimitochondrial Antibody Positivity Vary by Race/Ethnicity Among Patients With Primary Biliary CholangitisAllyce Caines, Mei Lu, Trueman Wu, et al.
Journal of Gastroenterology and Hepatology|April 20, 2026
Author Response to "Comment on Prediagnosis Alkaline Phosphatase and Antimitochondrial Antibody Positivity Vary by Race/Ethnicity Among Patients With Primary Biliary Cholangitis"Allyce Caines, Mei Lu, Trueman Wu, et al.
Gastroenterology|August 13, 2021
Defining Primary Sclerosing Cholangitis: Results From an International Primary Sclerosing Cholangitis Study Group Consensus ProcessCyriel Y Ponsioen, David N Assis, Kirsten M Boberg, et al.
Journal of Gastroenterology|November 11, 2006
Changes in plasma ghrelin levels, gastric ghrelin production, and body weight after Helicobacter pylori cureHiroyuki Osawa, Hiroto Kita, Hirohide Ohnishi, et al.
Journal of Autoimmunity|April 28, 2019
Therapeutic trials of biologics in primary biliary cholangitis: An open label study of abatacept and review of the literatureChristopher L Bowlus, Guo-Xiang Yang, Chung H Liu, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 26, 2018
RARβ acts as both an upstream regulator and downstream effector of miR-22, which epigenetically regulates NUR77 to induce apoptosis of colon cancer cellsYing Hu, Samuel W French, Thinh Chau, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 4, 2026
Impact of Disease-Specific Treatment and Non-Selective Beta Blockers on Risk of PVT in Cirrhotic Patients With HCV or PBCHumberto C Gonzalez, Stuart C Gordon, Sheri Trudeau, et al.
Frontiers in Immunology|September 5, 2022
Decreased CD57 expression of natural killer cells enhanced cytotoxicity in patients with primary sclerosing cholangitisBin Liu, Guo-Xiang Yang, Ying Sun, et al.
Hepatology (Baltimore, Md.)|October 19, 2011
Biochemical and immunologic effects of rituximab in patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acidMasanobu Tsuda, Yuki Moritoki, Zhe-Xiong Lian, et al.
Pageof 19